Evidence map›Paper›PMID 32326384›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Antimicrobial Activity of Silver-Treated Bacteria against other Multi-Drug Resistant Pathogens in Their Environment.

Doaa Safwat Mohamed, Rehab Mahmoud Abd El-Baky, Tim Sandle, Sahar A Mandour, Eman Farouk Ahmed

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Gallium Resistance inApplied microbiology (Basel, Switzerland) · 2025
    Article
  13. Biocidal Properties of New Silver Nanoparticles Argirium SUNcNanomaterials (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Medicine and pharmacy reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Doaa Safwat MohamedMicrobiology and Immunology Department, Faculty of Pharmacy, Deraya University, Minia 11566, Egypt.
Rehab Mahmoud Abd El-BakyMicrobiology and Immunology Department, Faculty of Pharmacy, Deraya University, Minia 11566, Egypt.ORCID 0000-0001-6094-5653
Tim SandleSchool of Health Sciences, Division of Pharmacy & Optometry, University of Manchester, Manchester M13 9NT, UK.ORCID 0000-0002-8304-8274
Sahar A MandourMicrobiology and Immunology Department, Faculty of Pharmacy, Deraya University, Minia 11566, Egypt.ORCID 0000-0003-2500-0480
Eman Farouk AhmedMicrobiology and Immunology Department, Faculty of Pharmacy, Deraya University, Minia 11566, Egypt.ORCID 0000-0003-0911-2503
Deraya UniversityUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver is a potent antimicrobial agent against a variety of microorganisms and once the element has entered the bacterial cell, it accumulates as silver nanoparticles with large surface area causing cell death. At the same time, the bacterial cell becomes a reservoir for silver. This study aims to test the microcidal effect of silver-killed

Indexed as

E. coli O104:H4polluted water and burn dressingsilver nanoparticlessustained release

Identifiers

PMID32326384
PMCPMC7235873
OpenAlexW3016639402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.